APA (7th ed.) Citation

Mastorino, L., Dapavo, P., Ortoncelli, M., Bongiovanni, E., Liao, Y., Leo, F., . . . Ribero, S. (2025). Dose Modulation Strategies in Psoriatic Patients: Real‐Life Pilot Comparison Between Risankizumab and Guselkumab up to 12 Months After Dose Spacing. Experimental Dermatology, 34(2), 1. https://doi.org/10.1111/exd.70062

Chicago Style (17th ed.) Citation

Mastorino, Luca, Paolo Dapavo, Michela Ortoncelli, Eleonora Bongiovanni, Yingying Liao, Francesco Leo, Pietro Quaglino, and Simone Ribero. "Dose Modulation Strategies in Psoriatic Patients: Real‐Life Pilot Comparison Between Risankizumab and Guselkumab Up to 12 Months After Dose Spacing." Experimental Dermatology 34, no. 2 (2025): 1. https://doi.org/10.1111/exd.70062.

MLA (9th ed.) Citation

Mastorino, Luca, et al. "Dose Modulation Strategies in Psoriatic Patients: Real‐Life Pilot Comparison Between Risankizumab and Guselkumab Up to 12 Months After Dose Spacing." Experimental Dermatology, vol. 34, no. 2, 2025, p. 1, https://doi.org/10.1111/exd.70062.